Grifols 2023 Annual Report on Form 20-F filed with the SEC
Grifols 2023 Annual Report on Form 20-F filed with the SEC
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
Grifols Plans First Bond Sale Since Short Seller Attack
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Grifols’ Financials Have No Big Errors, Spanish Regulator Says
Health Care Roundup: Market Talk
UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.